Reports for NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
Totals |
||
Shortage reports |
177 |
|
| Actual shortage: | 5 (3%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 5 (3%) | |
| Resolved: | 167 (94%) | |
Discontinuation Reports |
55 |
|
| To be discontinued: | 1 (2%) | |
| Discontinued: | 54 (98%) | |
| Reversed: | 0 (0%) | |
Late reports |
34 (15%) |
|
Overdue reports |
2 (33%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TOBRADEX | 0.1% 0.3% | OINTMENT | Resolved | 2017-06-23 | 2017-07-11 | 13861 |
| TOBRADEX | 0.1% 0.3% | OINTMENT | Resolved | 2017-07-27 | 2017-09-13 | 17414 |
| TOBRADEX | 0.1% 0.3% | OINTMENT | Resolved | 2017-09-18 | 2017-11-02 | 22359 |
| TOBRADEX | 0.1% 0.3% | OINTMENT | Resolved | 2018-12-19 | 2019-02-02 | 70039 |
| TOBRADEX | 0.1% 0.3% | OINTMENT | Resolved | 2025-04-28 | 2025-08-19 | 255935 |
| TOBRADEX | 0.1% 0.3% | SUSPENSION | Resolved | 2017-09-05 | 2017-09-14 | 20969 |
| TOBRADEX | 0.1% 0.3% | SUSPENSION | Resolved | 2022-07-21 | 2022-08-06 | 165184 |
| TOBREX | .3% | SOLUTION | Resolved | 2017-09-05 | 2017-09-14 | 20963 |
| TOBREX | .3% | SOLUTION | Resolved | 2018-12-11 | 2019-02-05 | 69257 |
| TOBREX | 3MG | OINTMENT | Resolved | 2018-01-08 | 2018-01-30 | 35259 |
| TOBREX | 3MG | OINTMENT | Resolved | 2019-01-08 | 2019-01-28 | 71609 |
| TOBREX | 3MG | OINTMENT | Resolved | 2019-02-11 | 2019-03-09 | 75340 |
| TOBREX | 3MG | OINTMENT | Resolved | 2019-03-11 | 2019-04-06 | 78252 |
| TOBREX | 3MG | OINTMENT | Resolved | 2019-04-08 | 2019-04-26 | 80771 |
| TOBREX | 3MG | OINTMENT | Resolved | 2019-06-21 | 2019-09-06 | 87200 |
| TOBREX | 0.3% | OINTMENT | Resolved | 2020-09-08 | 2021-02-24 | 123888 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2018-01-08 | 2018-02-08 | 35254 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2018-03-13 | 2018-04-25 | 42773 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2019-12-16 | 2019-12-19 | 101440 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2020-01-20 | 2020-04-17 | 103742 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AFINITOR | 7.5MG | TABLET | Discontinued | 2018-07-09 | 2018-07-10 | 54891 |
| ARZERRA | 100MG | SOLUTION | Discontinued | 2019-03-11 | 2019-03-12 | 78215 |
| ARZERRA | 1000MG | SOLUTION | Discontinued | 2019-03-11 | 2019-03-12 | 78219 |
| BETOPTIC S | 0.25% | SUSPENSION | Discontinued | 2022-09-28 | 2023-01-19 | 170389 |
| BETOPTIC S | 0.25% | SUSPENSION | Discontinued | 2025-03-11 | 2025-06-02 | 252361 |
| EXTAVIA | 0.3MG | POWDER FOR SOLUTION | Discontinued | 2022-01-12 | 2022-02-11 | 152532 |
| FLAREX | 0.1% | SUSPENSION | Discontinued | 2024-08-27 | 2024-11-28 | 235987 |
| FORADIL DRY POWDER CAPSULES FOR INHALATION | 12MCG | CAPSULE | Discontinued | 2022-10-18 | 2023-01-25 | 172087 |
| HYCAMTIN | 4MG | POWDER FOR SOLUTION | Discontinued | 2017-04-26 | 2019-06-11 | 8129 |
| ILARIS | 150MG | POWDER FOR SOLUTION | Discontinued | 2019-09-11 | 2019-09-12 | 93588 |
| ISOPTO CARPINE | 4% | LIQUID | Discontinued | 2022-05-11 | 2022-07-14 | 160361 |
| LAMISIL | 250MG | TABLET | To be discontinued | 2024-11-28 | 2024-11-28 | 244096 |
| LESCOL XL | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-03-20 | 2020-04-17 | 109153 |
| LIORESAL D.S. TAB 20MG | 20MG | TABLET | Discontinued | 2020-01-10 | 2020-02-24 | 103075 |
| LIORESAL INTRATHECAL 0.05MG/ML | 0.05MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201576 |
| LIORESAL INTRATHECAL 0.5MG/ML | 0.5MG | SOLUTION | Discontinued | 2023-08-17 | 2023-09-19 | 202298 |
| LIORESAL INTRATHECAL 2MG/ML | 2MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201573 |
| LIORESAL TAB 10MG | 10MG | TABLET | Discontinued | 2020-01-10 | 2020-07-10 | 103078 |
| LOPRESOR 100MG | 100MG | TABLET | Discontinued | 2018-01-09 | 2018-01-09 | 35454 |
| LOPRESOR 50MG | 50MG | TABLET | Discontinued | 2018-01-09 | 2019-03-20 | 35419 |